Medical device recalls Moderate risk

BD KIESTRA LAB AUTOMATION recalls BD Kiestra" ReadA; Catalog No.: 446948.

Recall date
February 6, 2026
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1658-2026
FDA classification
Class II
Brand / firm
BD KIESTRA LAB AUTOMATION
Sold / distributed
Domestic: KS, MD, MN, NJ, TX, VA; International: Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Hong Kong, Italy, Kuwait, Mexico, Morocco, Netherlands, Norway, Saudi Arabia, Spain, Sweden, Switzerland, Taiwan, United Kingdom;

Why it was recalled

In certain situations, following a system reboot, one or more modules may have become unreachable via the remote connectivity interface. When this occurred, there was potential for delays in plate retrieval from the incubator while connectivity was restored. This issue was intermittent and did not affect test results, performance of the assay, or sample integrity.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

BD Kiestra" ReadA; Catalog No.: 446948.

Get recall alerts

Free email alert whenever BD KIESTRA LAB AUTOMATION has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: BD KIESTRA LAB AUTOMATION